Connect with us

Technology

Rice breaks ground on the Arc in the Ion District, expanding Houston’s innovation ecosystem

Published

on

Nearly 200,000-square-foot research hub will connect Rice, industry and entrepreneurs to accelerate discovery, collaboration and commercialization

HOUSTON, Nov. 5, 2026 /PRNewswire/ — Rice University broke ground on the Arc in the Ion District, a nearly 200,000-square-foot research, corporate innovation and office building designed to bring researchers, industry leaders, entrepreneurs, investors and top talent together to accelerate innovation and move ideas from discovery to real-world application.

Located in Houston’s Ion District powered by Rice, the Arc will feature seven floors of flexible, future-ready lab and office space for Rice and other organizations seeking proximity to leading research, highly skilled workers and Houston’s dynamic innovation ecosystem. Rice will be a lead tenant, occupying nearly 80,000 square feet, or about 40% of the building.

“The Arc is a significant investment in Rice’s future and in Houston’s continued growth as a center for innovation,” said Robert T. Ladd, chairman of the Rice Board of Trustees. “It will create new opportunities for industry leaders, researchers and students to work together on ideas with the potential for lasting impact.”

The Arc will share a plaza with the Ion building, extending the 12-block Ion District and placing researchers in close proximity to companies, startups, investors and entrepreneurs.

“The Arc will bring Rice’s extraordinary research and talent and Houston’s impactful innovation ecosystem into even closer connection with the industries and innovators working to solve some of the world’s most consequential challenges,” said Rice President Reginald DesRoches. “That constant exchange of ideas and expertise will help move discoveries more rapidly from the laboratory to real-world impact.”

Built for advanced research and collaboration

The facility will offer flexible lab and office environments that can adapt to evolving research and business needs. Floor plates will range from 28,000 to 31,000 square feet, with 15-foot floor-to-floor heights and infrastructure capable of supporting advanced HVAC, high-capacity electrical and emergency power systems and core laboratory requirements.

The building will also include conference and meeting spaces, an amenity lounge, fitness center, outdoor plazas, underground parking, secure bike storage and on-site retail and dining — creating opportunities to build solutions in the lab, develop partnerships across the district and connect informally throughout the day. The project is designed to meet LEED Gold criteria and will incorporate smart-building and energy-saving features.

“We are creating more than a high-performance business and research building,” said Kelly Fox, Rice executive vice president for operations, finance and support. “The Arc is being designed as a destination where companies can access sophisticated infrastructure, connect with one another and build the relationships that lead to new ideas and opportunities.”

Work within the building will span areas including artificial intelligence and machine learning, data science, robotics, quantum science and engineering, energy and more.

The groundbreaking event comes on the heels of the university’s recent announcement of a transformational universitywide AI initiative to recruit 75 faculty members working across disciplines and expand AI-related courses and degrees. The initiative is accelerating Rice’s emergence as a global leader in advanced computing and responsible AI.

“The closer researchers are to the people confronting real-world problems, the more opportunities there are to identify important questions, test ideas and improve solutions,” said David Sholl, Rice executive vice president for research. “The Arc gives us an environment built specifically for that kind of sustained collaboration.”

AI Foundry to call the Arc home

Rice’s new AI Foundry will be located inside the Arc, where faculty AI experts will have offices and work with industry partners to tackle complex challenges, rapidly develop practical solutions and help organizations build long-term AI capabilities.

The effort will address a growing challenge: AI is advancing faster than many traditional industry innovation models can adapt. Instead of relying on lengthy, linear development cycles, the Foundry will bring Rice experts and industry partners together to identify high-value opportunities, design and test solutions, deploy them in real-world settings and continually refine them based on results.

The Foundry is envisioned to support organizations through AI readiness assessments, feasibility studies, proofs of concept, deployment-ready solutions, executive education and customized workforce training.

“The AI Foundry is exactly the kind of collaboration the Arc is designed to enable,” said Amy Dittmar, the Howard R. Hughes Provost and executive vice president for academic affairs. “By bringing Rice researchers together with industry partners in a shared environment, we can accelerate the movement of ideas from research into practical applications while helping organizations build the capabilities they need to succeed as AI continues to evolve.”

Responsible AI is a key catalyst in Momentous: Personalized Scale for Global Impact, Rice’s strategic plan, which also calls for strategic faculty growth and specifically identifies cross-disciplinary cluster hiring as a way to build depth and breadth in areas vital to the university’s future. The institution’s four AI cluster areas are foundational AI; two applied areas including AI for health and AI for energy, the environment and resiliency; and responsible AI: society and ethics.   

Building on the Ion’s momentum

The Arc will complement the Ion building, the namesake centerpiece of Houston’s innovation corridor and home to corporate and industry partners including Chevron, Microsoft, Aramco, ExxonMobil, Oxy, Shell, United, Transocean and Woodside Energy.

Co-working space in the Ion managed by Industrious is fully occupied, with more than 250 member companies. Activate, an organization that scientists and engineers become founders and move research toward commercialization, recently launched its third cohort of fellows. Twenty-five startups have participated in the program to date.

Companies based in the Ion, including Persona AI, CES Renewable, Greenflash Infrastructure and Cognite, also have experienced significant growth, reinforcing the building’s role as a home for emerging companies and technology-driven organizations. The Ion’s development also extends beyond offices and laboratories. MADabolic, a strength-training gym, recently opened in the building. Greentown Labs, Community Artists’ Collective and Pickle Lab are also among the organizations that call the district home.

Together, the Ion and the Arc are intended to create a more connected environment where researchers, entrepreneurs, established companies and the broader Houston community can work, meet and exchange ideas.

“Houston has an extraordinary concentration of industry expertise, capital, talent and entrepreneurial energy,” said Bobby Tudor, Rice alumnus and chairman of the Houston Energy Transition Initiative. “The Arc will help turn that concentration into action by creating more opportunities for breakthrough research to become technologies and companies.”

The project is being developed by Rice Real Estate Co. Construction is expected to be completed in the second quarter of 2028. Preleasing opportunities are now open for companies and organizations interested in locating alongside Rice researchers and joining the broader Ion District ecosystem.

For more information, visit https://www.thearciondistrict.com/.

About Rice University
Located on a 300-acre forested campus in Houston, Texas, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of architecture, business, continuing studies, engineering and computing, humanities and arts, music, natural sciences and social sciences and is home to the Baker Institute for Public Policy and Kinder Institute for Urban Research. Internationally, the university maintains the Rice Global Paris Center, a hub for innovative collaboration, research and inspired teaching located in the heart of Paris, and Rice Global India in Bengaluru, India. With 4,793 undergraduates and 4,185 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked in the top 10 for best quality of life by the Princeton Review. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rice-breaks-ground-on-the-arc-in-the-ion-district-expanding-houstons-innovation-ecosystem-302931374.html

SOURCE Rice University

Continue Reading

Technology

HiTHIUM Partners with the University of Cambridge to Advance International Industry-Academia Collaboration in Long-Duration Energy Storage

Published

on

By

XIAMEN, China, Nov. 14, 2026 /PRNewswire/ — On November 12, the Global Energy Storage Colloquium was held in Xiamen. During the colloquium, HiTHIUM and the University of Cambridge signed a memorandum of understanding (MoU), establishing a strategic partnership. The two parties will collaborate on frontier scientific research, key technology innovation and industrial applications in battery energy storage, bringing academic research into closer alignment with industry needs and exploring new models for international industry-academia collaboration. The partnership aims to contribute to the advancement of global energy storage technology and the industry.

The UK has a strong track record in the development of modern battery technologies and fundamental research. The University of Cambridge is one of the world’s leading universities, with internationally recognized expertise in engineering, materials science and fundamental research. As a leading global energy storage technology company, HiTHIUM has long focused on energy storage technology development and commercialization. It continues to advance integrated research and innovation across the value chain, from high-capacity energy storage cells to long-duration energy storage systems and grid integration technologies.

The collaboration is intended to bring internationally leading academic research into closer engagement with innovation across China’s energy storage industry. The University of Cambridge’s strengths in fundamental science, materials research and engineering will offer new perspectives and approaches to key scientific questions and emerging technologies in energy storage. HiTHIUM will bring its experience in long-duration energy storage (LDES), product development and large-scale deployment, connecting research with real industry needs and application scenarios, and supporting the engineering validation and commercialization of research outcomes. By drawing on the strengths of both research and industry, the partnership will strengthen the links between frontier innovation and practical applications.

Under the cooperation plan, the two parties will establish joint management and research collaboration mechanisms, bringing together academic resources and corporate R&D capabilities. They will work together to plan research projects, facilitate scientific exchange and support the translation of research outcomes, strengthening connections between fundamental research, technology development and industrial applications so that innovation in energy storage can better serve industry needs.

The partnership also marks an important step in HiTHIUM’s efforts to expand its international innovation network. Building on this collaboration with the University of Cambridge, HiTHIUM will further strengthen academic exchanges and research partnerships with leading universities and research institutions around the world. By bringing together international research resources and talent, the company aims to encourage collaboration across disciplines and technology fields, explore the development of technologies such as LDES from a global perspective, and bring technical challenges and application needs from the front lines of industry into research and innovation. This will help research and industrial practice reinforce one another.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hithium-partners-with-the-university-of-cambridge-to-advance-international-industry-academia-collaboration-in-long-duration-energy-storage-302939492.html

SOURCE HiTHIUM

Continue Reading

Technology

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Published

on

By

NEW YORK, Nov. 14, 2026 /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel — simply put No drill, No needle, or No filling.Tooth Decay is One of the Most Common Health Issues in the World2.5 billion people globally live with untreated tooth decay.Nearly 90% of U.S. adults have experienced tooth decay.Nearly 73% of U.S. adults report dental fear.21% avoid the dentist because of anxiety.The Story that Helped Shape vVARDISFor decades, treating early tooth decay often meant waiting until it worsened or getting a filling. The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.The technology has already treated more than 2.5 million teethAvailable in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-302939487.html

SOURCE New York Stock Exchange

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

on

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Trending